CoED Biosciences is developing disruptive technology that purifies, differentiates, expands, and functionalise immune cells from blood or tumour biopsies to be used in adoptive cell therapy or for research purposes.
Our technology can be used in the lab and we will work with our future customers to scale their pre-clinical studies to the clinic.